Health Care/Hospital

Gracell Announces Interim Readout of Investigation for First-in-class FasT CAR-19 in patients with Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia and Extension in Use of FasT CAR to Other Immune Cell Programs

SUZHOU and SHANGHAI, China, Sept. 12, 2019  /PRNewswire/ -- Gracell Biotechnologies Co., Ltd. ("Gracell"), a clinical-stage immune cell therapy company, today announced a positive continued clinical readout of a multi-center pilot study designed to evaluate the safety and efficacy of Gracell's f...

2019-09-12 05:00 4433

Gracell Announces Interim Readout of Investigation for First-in-class FasT CAR-19 in patients with Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia and Extension in Use of FasT CAR to Other Immune Cell Programs

SUZHOU and SHANGHAI, China, Sept. 11, 2019  /PRNewswire/ -- Gracell Biotechnologies Co., Ltd. ("Gracell"), a clinical-stage immune cell therapy company, today announced a positive continued clinical readout of a multi-center pilot study designed to evaluate the safety and efficacy of Gracell's f...

2019-09-12 05:00 2350

CIVCO Radiotherapy Presents Proton Head & Neck Immobilization Solution at ASTRO 2019 Annual Meeting

CORALVILLE, Iowa, Sept. 12, 2019 /PRNewswire/ -- CIVCO Radiotherapy, the leading global provider of high quality, innovative, patient-centric radiotherapy solutions, will present theirUniversal Couchtop™ proton system along with several new solutions and collaborative partnerships in booth #1814 ...

2019-09-12 04:30 1987

deCODE in Iceland Agrees to Sequence Half of UK Biobanks Participants

REYKJAVIK, Iceland, Sept. 12, 2019 /PRNewswire/ -- deCODE genetics in Iceland has entered into an agreement with a consortium of government, charity, researchers and world leading biopharmaceutical and healthcare companies to undertake whole genome sequencing of UK Biobank participants. The proje...

2019-09-12 00:25 2480

China Pharma Holdings, Inc. Has Entered into A Memorandum of Understanding With World Health Advanced Technologies, Ltd.

HAIKOU CITY, China, Sept. 11, 2019 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," "CPHI", the "Company" or "We"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based inChina, today announced that it has entered...

2019-09-11 20:00 7162

Ossur Technologies Featured in Nature Medicine Article Reporting for the First Time on Amputees "Feeling" Their Prosthetic Foot and Knee

REYKJAVIK, Iceland, Sept. 11, 2019 /PRNewswire/ -- An article published in the journalNature Medicine reports that two above knee lower-limb amputees who had intraneural electrodes implanted in their thighs and wore Ossur prosthetic componentry are the first in the world to "feel" their prostheti...

2019-09-11 19:31 7686

China SXT Pharmaceuticals, Inc. Granted to Establish Taizhou Research Center for Advanced TCMP Engineering Techniques

TAIZHOU, China, Sept. 11, 2019 /PRNewswire/ -- China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) ("China SXT" or the "Company"), a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces ("TCMPs"), including A...

2019-09-11 19:00 7502

3SBio's MSCI ESG Rating Upgraded to BBB, Ranking at the Forefront of the Global Biotechnology Industry

SHANGHAI, Sept. 11, 2019 /PRNewswire/ -- According to Morgan Stanley Capital International's (MSCI) latest set of ESG ratings, 3SBio has been upgraded to BBB status, surpassing that of 61% of companies in the global biotechnology industry. MSCI ESG ratings focus on ESG issues that have a substan...

2019-09-11 16:52 2609

Huawei FusionSolar Powers the World's Largest Medical Center in Jordan

AMMAN, Jordan, Sept. 11, 2019 /PRNewswire/ -- Huawei, a leading global ICT and network energy solutions provider, teamed up with Jordanian solar manufacturer and developer Philadelphia Solar to power the world's largest photovoltaic (PV) farm built for a single health care facility, Abdali Medica...

2019-09-11 16:45 4026

Merck Announces FDA Breakthrough Therapy Designation for Investigational Therapy Tepotinib in Patients with Metastatic NSCLC with METex14 Skipping Alterations

DARMSTADT, Germany, Sept. 11, 2019 /PRNewswire/ -- Merck, a leading science and technology company, today announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for the investigational targeted therapy tepotinib* in patients with metastatic non-small...

2019-09-11 14:30 2610

B&B Labs Debuts Anti-Acne Solutions to Tackle the 4 Stages of Acne

KUALA LUMPUR, Malaysia, Sept. 11, 2019 /PRNewswire/ -- On 1st September 2019, Award winning Asian cosmeceutical brand, B&B Labslaunched its latest plant-based anti-acne product line by merging cutting edge pharma-derma science andAsia's treasure trove of plant and herbal extracts. Although acne i...

2019-09-11 10:49 2550

Medix' commitment to social responsibility endorsed through world leading sustainability accreditation

LONDON and HONG KONG, Sept. 11, 2019 /PRNewswire/ -- Medix Group ("Medix" or the "Company"), a leading provider of innovative, high quality health management solutions, has received full accreditation from Global Reporting Initiative (GRI), the independent international organization that has pion...

2019-09-11 09:00 3268

CIVCO Radiotherapy Expands Proton Therapy Immobilization Solutions, Releases Universal Couchtop ProForm for Head & Neck Treatment

CORALVILLE, Iowa, Sept. 10, 2019 /PRNewswire/ -- CIVCO Radiotherapy, the leading global provider of high quality, innovative, patient-centric radiotherapy solutions, today announced the release of the Universal Couchtop™ ProForm™ Head & Neck Solution, the newest development in their ProtonSeri...

2019-09-11 05:30 2132

Vision Impact Institute Expands Advisory Board

Allyala Nandakumar and Serge Resnikoff Bring Expertise in Global Health and Vision DALLAS, Sept. 11, 2019 /PRNewswire/ -- The Vision Impact Institute (VII) is pleased to announce two new additions to the organization's Global Advisory Board.Allyala Nandakumar, Ph.D, and Serge Resnikoff, M.D., Ph...

2019-09-11 02:09 2215

Internationally awarded German med-tech innovation by Syntellix now produced in Singapore for the whole of Asia

SINGAPORE, Sept. 10, 2019 /PRNewswire/ -- In the presence of the German Ambassador and the Chairman of EDB Singapore, Syntellix Asia Pte Ltd inaugurates its production site in Tuas, which hosts the first dry CNC processing of such advanced magnesium alloys inAsia. Thus, Singapore becomes the Asi...

2019-09-10 22:14 2955

Blood Cancer Experts Discuss Latest Treatment Innovations at NCCN 2019 Annual Congress: Hematologic Malignancies™

Program includes debate and interactive case studies on emerging cancer care practices.#NCCNhem19. SAN FRANCISCO, Sept. 10, 2019 /PRNewswire/ -- World-renowned experts on blood cancers are meeting inSan Francisco on September 27-28, to help clinicians stay up-to-date on new, practice-changing st...

2019-09-10 20:35 1897

The First AI-powered Manuscript Submission Marketplace Connecting Authors and Journals

LONDON, Sept. 10, 2019 /PRNewswire/ -- Cactus Communications, a global scholarly, medical communication and technology solutions company, today launchedPubSURE -- the first marketplace that brings together researchers and journals across all STEM and HSS disciplines to make global scholarly publ...

2019-09-10 19:08 2444

The World Federation of Hemophilia (WFH) has spearheaded a scientific study updating the prevalence of hemophilia to higher numbers than previously estimated

MONTREAL, Sept. 10, 2019 /PRNewswire/ -- The World Federation of Hemophilia (WFH) has spearheaded a scientific study updating the prevalence of hemophilia to higher numbers than previously estimated and providing, for the first time, estimates of the prevalence of hemophilia at birth (Annals of I...

2019-09-10 19:03 1587

European Semifinalist of SEED AWARD was Unveiled, Highlighting the Integration of Technology and Humanity

GUANGZHOU, China, Sept. 10, 2019 /PRNewswire/ -- SEED AWARD, launched by Seedland Group, held its European Semifinal onSeptember 5, 2019, in London, where ten teams competed for three entries to the Global Final. SEED ...

2019-09-10 17:42 1903

KEYNOTE-024 Three-Year Survival Update: Pembrolizumab Effective as First-Line Therapy for Advanced Non-Small Cell Lung Cancer

BARCELONA, Spain, Sept. 10, 2019 /PRNewswire/ -- First-line pembrolizumab monotherapy provides durable long-term overall survival benefit compared to chemotherapy, according to data presented today by Dr. M. Reck, Lung Clinic Grosshansdorf, Airway Research Center North, Member of the German Cente...

2019-09-10 17:06 1583
1 ... 758759760761762763764 ... 802

Week's Top Stories